L. Andrieux, S. Langouet, A. Fautrel, F. Ezan, J. A. Krauser et al., Aryl Hydrocarbon Receptor Activation and Cytochrome P450 1A Induction by the Mitogen-Activated Protein Kinase Inhibitor U0126 in Hepatocytes, Molecular Pharmacology, vol.65, issue.4, pp.934-943, 2004.
DOI : 10.1124/mol.65.4.934

J. C. Barrett, Mechanisms of multistep carcinogenesis and carcinogen risk assessment, Environmental Health Perspectives, vol.100, pp.9-20, 1993.
DOI : 10.1289/ehp.931009

B. Bauvois, New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1825, issue.1, 2012.
DOI : 10.1016/j.bbcan.2011.10.001

R. Castillo-sanchez, S. Villegas-comonfort, O. Galindo-hernandez, R. Gomez, and E. P. Salazar, Benzo-[a]-pyrene induces FAK activation and cell migration in MDA-MB-231 breast cancer cells, Cell Biology and Toxicology, vol.63, issue.11, pp.303-319, 2013.
DOI : 10.1007/s10565-013-9254-1

P. Dabir, T. E. Marinic, I. Krukovets, and O. I. Stenina, Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial Cells, Circulation Research, vol.102, issue.12, pp.1558-1565, 2008.
DOI : 10.1161/CIRCRESAHA.108.176990

E. M. Del-amo, A. Urtti, and M. Yliperttula, Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2, European Journal of Pharmaceutical Sciences, vol.35, issue.3, pp.161-174, 2008.
DOI : 10.1016/j.ejps.2008.06.015

M. J. Drummond, E. L. Glynn, C. S. Fry, K. L. Timmerman, E. Volpi et al., An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle, AJP: Endocrinology and Metabolism, vol.298, issue.5, 2010.
DOI : 10.1152/ajpendo.00690.2009

E. A. Dunlop and A. R. Tee, Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms, Cellular Signalling, vol.21, issue.6, pp.827-835, 2009.
DOI : 10.1016/j.cellsig.2009.01.012

H. Imai, K. Kaira, N. Oriuchi, K. Shimizu, H. Tominaga et al., Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer, Anticancer Res, vol.30, pp.4819-4828, 2010.

H. Imai, K. Kaira, N. Oriuchi, N. Yanagitani, N. Sunaga et al., L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer, Histopathology, vol.13, issue.7, pp.804-813, 2009.
DOI : 10.1111/j.1365-2559.2009.03300.x

M. Jaguin, O. Fardel, and V. Lecureur, AhR-dependent secretion of PDGF-BB by human classically activated macrophages exposed to DEP extracts stimulates lung fibroblast proliferation, Toxicology and Applied Pharmacology, vol.285, issue.3, pp.170-178, 2015.
DOI : 10.1016/j.taap.2015.04.007
URL : https://hal.archives-ouvertes.fr/hal-01146840

K. Kaira, N. Oriuchi, H. Imai, K. Shimizu, N. Yanagitani et al., Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma, Lung Cancer, vol.66, issue.1, pp.120-126, 2009.
DOI : 10.1016/j.lungcan.2008.12.015